Matsuda Masaru (CIK 0001798679)

Latest company ownership

Shares held
152,298
Last filed at
Dec 3, 2025
Confidence Score
29.0
2025Q4
Confidence Score History
2022Q2 2025Q4
HALO - HALOZYME THERAPEUTICS, INC.
Role: SVP, General Counsel
Shares held
6,883
Last filed at
Sep 7, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 1, 2025 Dec 3, 2025 Arcutis Biotherapeutics, Inc. Officer Sell 45.0 -1,657 -1.09% ✓ $50.1K
Nov 19, 2025 Nov 21, 2025 Arcutis Biotherapeutics, Inc. Officer Sell 42.5 -2,550 -1.66% ✗ $72.1K
Nov 3, 2025 Nov 5, 2025 Arcutis Biotherapeutics, Inc. Officer Sell 42.5 -7,208 -4.47% ✗ $178.2K
Sep 4, 2025 Sep 8, 2025 Arcutis Biotherapeutics, Inc. Officer Sell 17.5 -36,130 -18.31% ✓ $583.7K
Aug 4, 2025 Aug 5, 2025 Arcutis Biotherapeutics, Inc. Officer Sell 42.5 -6,330 -3.11% ✗ $90.7K
May 28, 2025 May 29, 2025 Arcutis Biotherapeutics, Inc. Officer Sell 48.8 -1,800 -0.88% ✗ $24.8K
May 2, 2025 May 5, 2025 Arcutis Biotherapeutics, Inc. Officer Sell 42.5 -5,030 -2.40% ✗ $76.5K
Feb 28, 2025 Mar 4, 2025 Arcutis Biotherapeutics, Inc. Officer Sell 91.3 +30,737 17.20% ✗ $42.5K
Feb 3, 2025 Feb 4, 2025 Arcutis Biotherapeutics, Inc. Officer Sell 42.5 -8,338 -4.46% ✗ $105.9K
May 31, 2024 Dec 3, 2024 Arcutis Biotherapeutics, Inc. Officer Buy 83.8 +5,657 3.12% ✗ $18.5K
Nov 18, 2024 Nov 19, 2024 Arcutis Biotherapeutics, Inc. Officer Sell 78.8 +3,100 1.74% ✗ $17.2K
Nov 4, 2024 Nov 5, 2024 Arcutis Biotherapeutics, Inc. Officer Sell 46.3 -5,015 -2.74% ✗ $43.6K
Aug 2, 2024 Aug 5, 2024 Arcutis Biotherapeutics, Inc. Officer Sell 45.0 -5,220 -2.77% ✓ $47.1K
May 27, 2024 May 29, 2024 Arcutis Biotherapeutics, Inc. Officer Sell 78.8 +3,100 1.67% ✗ $16K
May 2, 2024 May 3, 2024 Arcutis Biotherapeutics, Inc. Officer Sell 45.0 -5,016 -2.63% ✓ $43.8K
Mar 4, 2024 Mar 6, 2024 Arcutis Biotherapeutics, Inc. Officer Sell 48.8 -3,760 -1.94% ✓ $41.8K
Nov 18, 2023 Nov 21, 2023 Arcutis Biotherapeutics, Inc. Officer Sell 85.0 +3,025 6.94% ✗ $3.7K
May 27, 2023 Jun 2, 2023 Arcutis Biotherapeutics, Inc. Officer Sell 91.3 +4,508 11.53% ✗ $14.3K
Mar 2, 2023 Mar 6, 2023 Arcutis Biotherapeutics, Inc. Officer Sell 91.3 +19,566 100.16% ✓ $22.7K
Nov 18, 2022 Nov 22, 2022 Arcutis Biotherapeutics, Inc. Officer Sell 91.3 +3,155 19.26% ✗ $31.3K
May 27, 2022 Jun 2, 2022 Arcutis Biotherapeutics, Inc. SVP and General Counsel Sell 91.3 +3,080 23.16% ✗ $35.4K
Sep 4, 2021 Sep 7, 2021 HALOZYME THERAPEUTICS, INC. SVP, General Counsel Sell 42.5 -3,412 -14.54% ✗ $144.1K
Feb 10, 2021 Feb 12, 2021 HALOZYME THERAPEUTICS, INC. SVP, General Counsel Sell 40.0 -5,250 -14.45% ✗ $264.1K
Sep 4, 2020 Sep 4, 2020 HALOZYME THERAPEUTICS, INC. SVP, General Counsel Sell 42.5 -2,380 -17.22% ✗ $65.9K
Feb 12, 2020 Feb 13, 2020 HALOZYME THERAPEUTICS, INC. SVP, General Counsel Sell 46.3 -1,681 -19.50% ✗ $33.6K